Sphere Medical Holding PLC’s (SPHR) “Buy” Rating Reaffirmed at Panmure Gordon
Panmure Gordon reaffirmed their buy rating on shares of Sphere Medical Holding PLC (LON:SPHR) in a research report sent to investors on Friday morning. The brokerage currently has a GBX 17 ($0.22) price objective on the stock.
Sphere Medical Holding PLC (LON:SPHR) traded up 1.70% during midday trading on Friday, hitting GBX 11.95. 48,272 shares of the stock traded hands. Sphere Medical Holding PLC has a one year low of GBX 6.00 and a one year high of GBX 15.00. The company’s market cap is GBX 16.94 million. The company’s 50 day moving average is GBX 11.65 and its 200-day moving average is GBX 11.10.
About Sphere Medical Holding PLC
Sphere Medical Holding PLC is a United Kingdom-based Company specializing in the development of medical monitoring and diagnostic equipment. The Company’s products include Proxima and Pelorus. Proxima is an arterial blood gas analyser which supports rapid and frequent measurement. It is operated using the dedicated bedside monitor with touch screen interface.
Receive News & Ratings for Sphere Medical Holding PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sphere Medical Holding PLC and related companies with MarketBeat.com's FREE daily email newsletter.